Perkins Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $813K | Sell |
33,759
-2,150
| -6% | -$56.2K | 0.61% | 38 |
|
|
2026
Q1 | $1.01M | Sell |
35,909
-1,400
| -4% | -$37.3K | 0.95% | 29 |
|
|
2025
Q4 | $929K | Sell |
37,309
-1,700
| -4% | -$42.9K | 0.74% | 41 |
|
|
2025
Q3 | $994K | Sell |
39,009
-1,450
| -4% | -$35.8K | 0.88% | 37 |
|
|
2025
Q2 | $981K | Sell |
40,459
-375
| -0.9% | -$8.74K | 0.99% | 33 |
|
|
2025
Q1 | $1.03M | Sell |
40,834
-750
| -2% | -$19.6K | 1.09% | 28 |
|
|
2024
Q4 | $1.1M | Buy |
41,584
+1,475
| +4% | +$40K | 0.98% | 36 |
|
|
2024
Q3 | $1.16M | Sell |
40,109
-5,566
| -12% | -$162K | 1.09% | 30 |
|
|
2024
Q2 | $1.28M | Sell |
45,675
-66
| -0.1% | -$1.82K | 1.2% | 26 |
|
|
2024
Q1 | $1.27M | Hold |
45,741
| – | – | 1.06% | 34 |
|
|
2023
Q4 | $1.32M | Sell |
45,741
-2,500
| -5% | -$75.6K | 1.12% | 30 |
|
|
2023
Q3 | $1.6M | Sell |
48,241
-100
| -0.2% | -$3.54K | 1.59% | 20 |
|
|
2023
Q2 | $1.77M | Sell |
48,341
-1,000
| -2% | -$38.9K | 1.55% | 23 |
|
|
2023
Q1 | $2.01M | Sell |
49,341
-1,075
| -2% | -$46.4K | 1.9% | 15 |
|
|
2022
Q4 | $2.58M | Sell |
50,416
-800
| -2% | -$38.4K | 2.73% | 10 |
|
|
2022
Q3 | $2.24M | Sell |
51,216
-1,807
| -3% | -$87.8K | 2.51% | 10 |
|
|
2022
Q2 | $2.78M | Sell |
53,023
-250
| -0.5% | -$12.7K | 2.88% | 8 |
|
|
2022
Q1 | $2.76M | Sell |
53,273
-975
| -2% | -$50.6K | 2.26% | 9 |
|
|
2021
Q4 | $3.2M | Sell |
54,248
-50
| -0.1% | -$2.48K | 2.16% | 9 |
|
|
2021
Q3 | $2.33M | Buy |
54,298
+3,450
| +7% | +$153K | 1.45% | 24 |
|
|
2021
Q2 | $1.99M | Buy |
50,848
+1,920
| +4% | +$74.7K | 1.13% | 33 |
|
|
2021
Q1 | $1.77M | Sell |
48,928
-620
| -1% | -$22K | 1.03% | 36 |
|
|
2020
Q4 | $1.82M | Sell |
49,548
-1,437
| -3% | -$52.7K | 1.19% | 31 |
|
|
2020
Q3 | $1.77M | Buy |
+50,985
| New | +$1.79M | 1.63% | 20 |
|
|
2020
Q1 | $1.71M | Buy |
55,069
+113
| +0.2% | +$3.85K | 2.06% | 14 |
|
|
2019
Q4 | $2.04M | Sell |
54,956
-6,640
| -11% | -$237K | 1.83% | 14 |
|
|
2019
Q3 | $2.1M | Buy |
61,596
+527
| +0.9% | +$19.2K | 1.81% | 14 |
|
|
2019
Q2 | $2.51M | Sell |
61,069
-1,590
| -3% | -$63.1K | 1.76% | 18 |
|
|
2019
Q1 | $2.52M | Sell |
62,659
-7,995
| -11% | -$320K | 1.66% | 17 |
|
|
2018
Q4 | $2.93M | Sell |
70,654
-564
| -0.8% | -$23.4K | 2.27% | 7 |
|
|
2018
Q3 | $2.98M | Buy |
71,218
+422
| +0.6% | +$16.2K | 1.79% | 11 |
|
|
2018
Q2 | $2.44M | Buy |
70,796
+2,846
| +4% | +$97.3K | 1.75% | 9 |
|
|
2018
Q1 | $2.29M | Buy |
67,950
+6,888
| +11% | +$237K | 2.06% | 7 |
|
|
2017
Q4 | $2.1M | Buy |
61,062
+6,324
| +12% | +$216K | 2.02% | 7 |
|
|
2017
Q3 | $1.85M | Sell |
54,738
-264
| -0.5% | -$8.48K | 1.94% | 13 |
|
|
2017
Q2 | $1.75M | Sell |
55,002
-1,997
| -4% | -$63K | 1.94% | 11 |
|
|
2017
Q1 | $1.85M | Sell |
56,999
-211
| -0.4% | -$6.65K | 1.91% | 10 |
|
|
2016
Q4 | $1.76M | Sell |
57,210
-369
| -0.6% | -$11.3K | 1.93% | 11 |
|
|
2016
Q3 | $1.85M | Sell |
57,579
-1,054
| -2% | -$35.2K | 1.85% | 12 |
|
|
2016
Q2 | $1.96M | Sell |
58,633
-6,377
| -10% | -$204K | 2.25% | 9 |
|
|
2016
Q1 | $1.83M | Hold |
65,010
| – | – | 2.29% | 7 |
|
|
2015
Q4 | $1.99M | Sell |
65,010
-2,108
| -3% | -$66.3K | 2.14% | 9 |
|
|
2015
Q3 | $2M | Sell |
67,118
-263
| -0.4% | -$8.43K | 2.23% | 7 |
|
|
2015
Q2 | $2.14M | Buy |
67,381
+369
| +0.6% | +$12K | 1.88% | 8 |
|
|
2015
Q1 | $2.21M | Sell |
67,012
-264
| -0.4% | -$8.39K | 1.85% | 9 |
|
|
2014
Q4 | $1.99M | Hold |
67,276
| – | – | 1.71% | 11 |
|
|
2014
Q3 | $1.89M | Hold |
67,276
| – | – | 1.59% | 14 |
|
|
2014
Q2 | $1.89M | Sell |
67,276
-1,413
| -2% | -$40.3K | 1.33% | 21 |
|
|
2014
Q1 | $2.09M | Sell |
68,689
-2,635
| -4% | -$78.6K | 1.47% | 19 |
|
|
2013
Q4 | $2.07M | Hold |
71,324
| – | – | 1.4% | 17 |
|
|
2013
Q3 | $1.94M | Sell |
71,324
-4,855
| -6% | -$132K | 1.4% | 20 |
|
|
2013
Q2 | $2.02M | Buy |
+76,179
| New | +$2.1M | 1.61% | 17 |
|
Other funds holding PFE
Perkins Capital Management's PFE Position: Q2 2026 in Review
Perkins Capital Management reduced its Pfizer (PFE) stake by 6% in Q2 2026, selling an estimated $56.2K and leaving 33,759 shares worth $813K. The position accounts for 0.61% of the portfolio, ranked #38.
Perkins Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.2M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Perkins Capital Management held 33,759 shares of Pfizer worth $813K as of Q2 2026.
- Perkins Capital Management sold 2,150 Pfizer shares in Q2 2026, an estimated $56.2K.
- Pfizer made up 0.61% of Perkins Capital Management's portfolio in Q2 2026, its #38 holding.
- Perkins Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Perkins Capital Management's Pfizer position peaked at $3.2M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.